Clinical trial

The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC

NCT04839055

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Coenzyme A Combined With Abiraterone Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Abiraterone Normalized identity: abirateroneView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-03-18

PhasePHASE1 / PHASE2

Conditions

Castration-resistant Prostate Cancerunresolved

Interventions

Coenzyme A Combined With AbirateroneDRUG

AbirateroneDRUG · verified · RxNorm: abiraterone

Sponsors & collaborators

Jiangnan Universitylead sponsor

Affiliated Hospital of Jiangnan Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04839055 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.